Among the cytokines, NAFLD patients show increased circulating levels of resistin [244,245], and TNF-α not only mediates the early stages of NAFLD but also transitions to more advanced stages of liver damage [246,247,248]. The gene discussed is TNF; the disease is metabolic dysfunction-associated steatotic liver disease.